Schonfeld Strategic Advisors LLC Axonics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 11,548 shares of AXNX stock, worth $811,708. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,548

Holding current value

$811,708

% of portfolio

0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $767,595 - $804,318	11,548 New	11,548 $776,000
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $585,478 - $734,562	12,200 New	12,200 $615,000
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $125,076 - $160,860	2,100 Added 3.97%	55,000 $3.44 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $3.07 Million - $4.13 Million	52,900 New	52,900 $3.73 Million
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $1.25 Million - $1.79 Million	-28,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $1.43 Million - $2.1 Million	28,600 New	28,600 $1.6 Million
Q3 2021 Nov 16, 2021	SELL	$59.21 - $78.66 $794,894 - $1.06 Million	-13,425 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $689,910 - $898,132	13,425 New	13,425 $851,000
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $481,572 - $586,922	-9,800 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $1.24 Million - $1.51 Million	-29,316 Reduced 74.95%	9,800 $489,000
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $288,999 - $417,507	-8,180 Reduced 17.3%	39,116 $2,000
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $1.08 Million - $1.88 Million	47,296 New	47,296 $1.66 Million
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $1.64 Million - $3.76 Million	-99,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $1.03 Million - $1.52 Million	52,600 Added 111.68%	99,700 $2.76 Million
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $193,824 - $305,352	7,200 Added 18.05%	47,100 $1.27 Million
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $278,100 - $614,550	15,000 Added 60.24%	39,900 $1.63 Million
Q1 2019 May 15, 2019	SELL	$13.32 - $24.35 $51,948 - $94,965	-3,900 Reduced 13.54%	24,900 $596,000
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $380,160 - $473,184	28,800 New	28,800 $435,000

Others Institutions Holding AXNX

# of Institutions

239

Shares Held

42.8M

Call Options Held

73.7K

Put Options Held

230K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.45B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Axonics, Inc. Transaction History